Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Merck
MRK
|
$2.43B |
| 2 |
Abbott
ABT
|
$1.44B |
| 3 |
Honeywell
HON
|
$1.01B |
| 4 |
Emerson Electric
EMR
|
$756M |
| 5 |
American International
AIG
|
$749M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.76B |
| 2 |
TJX Companies
TJX
|
$1.65B |
| 3 |
Baxter International
BAX
|
$1.17B |
| 4 |
Amazon
AMZN
|
$937M |
| 5 |
Starbucks
SBUX
|
$850M |
Sector Composition
| 1 | Healthcare | 24.3% |
| 2 | Technology | 15.49% |
| 3 | Financials | 14.45% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Stryker
SYK
$150B
| $4.16B | 0.83% | 17,030,078 -619,312 | -4% | -$151M |
|
27
Morgan Stanley
MS
$240B
| $3.91B | 0.78% | 45,993,894 -3,215,552 | -7% | -$273M |
|
28
Humana
HUM
$36.5B
| $3.9B | 0.78% | 7,611,181 -1,364,505 | -15% | -$699M |
|
29
Nike
NKE
$114B
| $3.82B | 0.77% | 32,637,156 -635,224 | -2% | -$74.3M |
|
30
Coca-Cola
KO
$297B
| $3.82B | 0.77% | 60,024,533 -5,478,487 | -8% | -$348M |
|
31
AstraZeneca
AZN
$248B
| $3.7B | 0.74% | 54,606,052 +2,359,136 | +5% | +$160M |
|
32
Northrop Grumman
NOC
$84.5B
| $3.56B | 0.71% | 6,526,505 -291,663 | -4% | -$159M |
|
33
Johnson Controls International
JCI
$69.9B
| $3.52B | 0.71% | 55,028,882 -10,425,090 | -16% | -$667M |
|
34
General Dynamics
GD
$87.3B
| $3.45B | 0.69% | 13,909,259 -1,003,638 | -7% | -$249M |
|
35
HCA Healthcare
HCA
$94.5B
| $3.45B | 0.69% | 14,369,349 +371,319 | +3% | +$89.1M |
|
36
American Express
AXP
$231B
| $3.22B | 0.65% | 21,818,034 -1,866,960 | -8% | -$276M |
|
37
EOG Resources
EOG
$68.2B
| $3.1B | 0.62% | 23,920,005 +5,779,996 | +32% | +$749M |
|
38
Accenture
ACN
$162B
| $3.06B | 0.61% | 11,463,437 +170,379 | +2% | +$45.5M |
|
39
Duke Energy
DUK
$95.3B
| $2.9B | 0.58% | 28,193,840 -5,863,211 | -17% | -$604M |
|
40
Colgate-Palmolive
CL
$67.9B
| $2.87B | 0.58% | 36,427,142 -2,462,469 | -6% | -$194M |
|
41
MetLife
MET
$54.1B
| $2.82B | 0.57% | 39,004,175 -1,492,919 | -4% | -$108M |
|
42
American Tower
AMT
$95.5B
| $2.8B | 0.56% | 13,238,663 +1,320,263 | +11% | +$280M |
|
43
Boston Scientific
BSX
$156B
| $2.67B | 0.54% | 57,736,340 -4,800,659 | -8% | -$222M |
|
44
Linde
LIN
$224B
| $2.61B | 0.52% | 7,991,836 -169,284 | -2% | -$55.2M |
|
45
Becton Dickinson
BDX
$55.3B
| $2.55B | 0.51% | 10,012,054 -913,221 | -8% | -$232M |
|
46
Marsh & McLennan
MMC
$101B
| $2.43B | 0.49% | 14,690,553 -475,836 | -3% | -$78.7M |
|
47
Deere & Co
DE
$129B
| $2.43B | 0.49% | 5,658,061 -343,155 | -6% | -$147M |
|
48
Progressive
PGR
$145B
| $2.4B | 0.48% | 18,539,094 -2,733,115 | -13% | -$355M |
|
49
Canadian National Railway
CNI
$60.4B
| $2.4B | 0.48% | 20,186,602 -525,166 | -3% | -$62.3M |
|
50
Sysco
SYY
$38.5B
| $2.38B | 0.48% | 31,128,214 -1,051,980 | -3% | -$80.4M |
|